GROUP WEBSITES MENU LIAISON® MeMed BV® The innovative new solution for accurate and rapid differentiation between bacterial and viral infections READ MORE SCOPRI DI PIÙ DIASORIN, THE DIAGNOSTIC SPECIALIST We are global leader in the laboratory diagnostics market, specializing in the immunodiagnostics and molecular diagnostics segments. For over 50 years our Group has been developing, producing and commercializing diagnostic tests: we support clinical laboratory needs and activities, providing solutions that are reliable, innovative, fully automated and standardized. We continually invest in Research & Development, using our own distinctive expertise in the field to deliver a high level of innovation. OUR COMPANY CLINICAL AREAS We offer the broadest range of specialty tests available in the immunodiagnostics market. DISCOVER ALL AREAS DISCOVER OUR MENU LIAISON® XS All our technology in a new dimension. LIAISON® XS delivers a high technology solution for immunochemistry tests that allows laboratories to improve efficiency and clinical effectiveness for routine and specialty testing. DISCOVER ALL SYSTEMS WORLDWIDE PRESENCE Our Group consists of 22 branches with offices across 5 continents and manufacturing premises producing its tests in 5 sites around the world. WHERE WE ARE NEWS 14/07/2021 The acquisition of Luminex Corporation represents an important step in the expansion strategy of DiaSorin… Read the press release 12/07/2021 ECCMID ‘21: Integrated Symposium Diagnosis and immune response of SARS-CoV-2 infection, Flash session TrimericS IgG serology assay in heterologous vaccination. Register to access 08/02/2021 DiaSorin launches with CE mark the LIAISON® SARS-CoV-2 TrimericS IgG assay, a new quantitative serology test for determination of IgG antibodies against SARS-CoV-2. Read the press release 26/10/2020 DiaSorin launches with CE mark the LIAISON® SARS-CoV-2 Ag, a new high-throughput antigen test for COVID-19 detection in symptomatic patients. Read the press release ALL NEWS Discover DIASORIN APP FOR LABORATORIES NEW LABELING & PACKAGING Contacts HEADQUARTER Via Crescentino Snc 13040 Saluggia (VC) Centralino Tel. +39 0161 487.1 MARKETING Tel. +39 0161 487.1 marketing@diasorin.it Diasorin Group Diasorin Molecular Luminex Corporation Privacy Policy Legal Notices Modern Slavery Act Statement DiaSorin S.p.A. - Capitale Sociale €55.948.257 R.E.A. 180729 Fiscal Code and Subscription to Vercelli Companies Register no 13144290155

GROUP WEBSITES INSTRUMENTS PRODUCTS SUPPORT NEWS & EVENTS EDUCATION ABOUT US ORDERS & DELIVERY INT Search DIASORIN'S RESPONSE TO THE COVID-19 OUTBREAK Simplexa™ COVID-19 Direct Kit Enabling Swift Action Against the COVID-19 Pandemic LEARN MORE Welcome to the DiaSorin Molecular Site Please select your location below. By selecting the International view, you verify that you reside outside of the USA and you wish to view DiaSorin Molecular's International Product Information. This material is intended for International (non-USA) site visitors only. Choose your location: INTERNATIONAL US